Oropharyngeal cancers testing in Ottone
Find health labs to test for Oropharyngeal cancers in Ottone and compare all offers by prices and services.
Tests that cover Oropharyngeal cancers
HPV Test
Pap Test by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
test HPV cavo orale autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
Pap Smear by Laboratorio Lifebrain
Via Vastato, 44/1 16036 Recco (GE)
20.2 km
Pap Smear by Synlab
Via Gelasio Adamoli, 57, 16141 Genova GE, Italia
24.5 km
Pap Smear by Synlab
Via Marco Sala, 36, 16167 Genova GE, Italia
24.5 km
Pap Smear by Synlab
Via Angelo Gianelli, 75R, 16166 Genova GE, Italia
24.5 km
Pap Test by Casa della Salute
Via Giacomo Poirè, 27, 16010 Sant'Olcese GE, Italia
20.3 km
Pap Smear by Laboratorio Lifebrain
via Pieve di Cadore, 12/B Rosso 16164 Genova (GE)
24.5 km
Pap Smear by Laboratorio Lifebrain
Via Gavino, 94 rosso 16014 Campomorone (GE)
23.1 km
Pap Smear by Synlab
Corso Alessandro De Stefanis, 1, 16139 Genova GE, Italia
24.5 km
Pap Smear by Synlab
Via Montallegro, 48, 16145 Genova GE, Italia
24.5 km
Pap Smear by Synlab
Via Montallegro, 48, 16145 Genova GE, Italia
24.5 km
Oropharyngeal cancers - symptoms and how to test
Head and neck cancers include oropharyngeal cancer. Cancers affecting the oral cavity, nose, pharynx, larynx (voice box), trachea, and oesophagus can sometimes arise together. Oral cavity malignancies are primarily squamous cell carcinomas. Men are twice as likely as women to have this malignancy. It happens to both African Americans and Caucasians in roughly the same numbers. On average, a diagnosis is made among people 62 and older. Individuals younger than 55 account for around 25% of all cases of oropharyngeal cancer. Due to the increased risk of oesophagal cancer in patients with oral and oropharyngeal malignancies, your doctor may decide to request the screening. Examining the patient's swallowing function can also help determine whether or not the malignancy is creating any difficulties.
